Literature DB >> 22256981

Leucopenia associated with abalone viral ganglioneuritis.

C Hooper1, R Slocombe, R Day, S Crawford.   

Abstract

OBJECTIVE: To compare microscopic lesion severity with circulating total haemocyte counts (THC) in abalone affected by abalone viral ganglioneuritis (AVG).
RESULTS: A herpes-like virus led to severe mortality in a number of Australian abalone farms in 2006. The infection was associated with severe necrotising ganglioneuritis. The microscopic lesions were well demarcated, affecting the neural tissue almost exclusively and were characterised by necrosis and increased cellularity in affected ganglia and nerves. On two farms, the presence or absence of typical AVG pathology was compared with THC. Those abalone with microscopic lesions of AVG had significantly lower haemocyte counts. The mean THC in abalone with no evidence of AVG from both farms was 4.6 × 10(6)/mL (±0.3 SE). The THC in AVG-affected abalone in farm 1 was 2.8 × 10(6)/mL (±0.5 SE) and farm 2 was 0.98 × 10(6)/mL (±0.4 SE).
CONCLUSIONS: Severe AVG is associated with leucopenia in affected abalone.
© 2012 The Authors. Australian Veterinary Journal © 2012 Australian Veterinary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22256981     DOI: 10.1111/j.1751-0813.2011.00877.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  2 in total

1.  Treatment effect of low intensity pulsed ultrasound on leukopenia induced by cyclophosphamide in rabbits.

Authors:  Baoru Liu; Yueping Luo; Dong Luo; Weichen Zhou; Yu Zhang; Ruixin He; Junshu Li; Yong Wang; Yan Wang; Wenzhi Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  The clinical value of Huangqi injection in the treatment of leucopenia: a meta-analysis of clinical controlled trials.

Authors:  Changsong Zhang; Changtai Zhu; Yang Ling; Xifa Zhou; Chunlei Dong; Judong Luo; Yongping Liu
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.